Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4220 |  TIL Instil Bio, Inc. - Common Stock | 6.56 USD | -4.23% | -8.76% | -13.00% | -66.34% | 44.49 M USD | ||
| 4223 |  CALC CalciMedica, Inc. - Common Stock | 1.30 USD | -12.16% | -20.73% | -41.44% | -61.54% | 44.38 M USD | ||
| 4227 |  HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.91 USD | -1.09% | +2.25% | -5.21% | -49.72% | 44.23 M USD | ||
| 4239 |  GRCE Grace Therapeutics, Inc. - Common Stock | 2.04 USD | -2.86% | 0.00% | -8.93% | -48.74% | 42.91 M USD | ||
| 4255 |  VERU Veru Inc. - Common Stock | 2.42 USD | -1.63% | -3.59% | -3.97% | +1.26% | 41.26 M USD | ||
| 4258 |  LNAI Lunai Bioworks Inc. - Common Stock | 1.12 USD | +2.75% | -23.29% | -56.42% | -8.20% | 40.62 M USD | ||
| 4285 |  MGX Metagenomi Therapeutics, Inc. - Common Stock | 0.99 USD | +1.02% | -9.17% | -13.91% | -31.25% | 37.40 M USD | ||
| 4288 |  LITS Lite Strategy, Inc. - Common Stock | 1.22 USD | -3.94% | -16.44% | +22.00% | -58.08% | 37.10 M USD | ||
| 4309 |  EDSA Edesa Biotech, Inc. - Common Shares | 3.66 USD | -5.91% | -8.73% | -23.75% | +37.08% | 35.29 M USD | ||
| 4321 |  GRDX GridAI Technologies Corp. - Common Stock | 4.80 USD | +16.50% | +34.83% | +59.47% | +88.24% | 34.23 M USD | ||
| 4327 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.92 USD | -2.00% | -8.84% | +9.50% | -69.28% | 34.10 M USD | ||
| 4331 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.08 USD | 0.00% | -6.09% | -13.60% | +3.85% | 33.96 M USD | ||
| 4332 |  CVM Cel-Sci Corporation Common Stock | 1.93 USD | -9.39% | -9.81% | +24.52% | -62.52% | 33.95 M USD | ||
| 4339 |  NNVC NanoViricides, Inc. Common Stock | 1.31 USD | -9.03% | +4.80% | +25.96% | +29.70% | 33.44 M USD | ||
| 4342 |  ALGS Aligos Therapeutics, Inc. - Common stock | 5.31 USD | -0.19% | -7.17% | -1.30% | -45.76% | 33.12 M USD | ||
| 4365 |  NXTC NextCure, Inc. - Common Stock | 6.78 USD | +3.35% | +31.14% | -15.14% | -48.24% | 31.03 M USD | ||
| 4372 |  QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 USD | +9.88% | -2.78% | -2.13% | +1298.10% | 29.86 M USD | ||
| 4382 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.71 USD | -2.84% | +8.23% | -0.58% | -82.02% | 28.95 M USD | ||
| 4383 |  IGC IGC Pharma, Inc. Common Stock | 0.28 USD | 0.00% | 0.00% | 0.00% | +7.69% | 28.95 M USD | ||
| 4394 |  CNTX Context Therapeutics Inc. - Common Stock | 0.30 USD | -3.23% | -3.23% | -18.92% | -79.59% | 27.56 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |